CLEVELAND, Sept. 20, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will hold a meeting for analysts and investorson Monday, September 25, 2017, during the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego.
The meeting will include breakfast, a company update
Event: ViewRay Analyst & Investor MeetingDate: Monday, September 25, 2017 Time: 7:00 – 8:30 a.m. PTLocation: Marriott Marquis, 333 W Harbor Dr. San Diego, CA, South Tower, Level 3
An audio webcast of the presentation will be available on the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 90 days after the date of the presentation.
To attend the live event, please RSVP to Brian Johnston at email@example.com.
About ViewRayViewRay®, Inc. (Nasdaq: VRAY) designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.
ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
View original content:http://www.prnewswire.com/news-releases/viewray-to-host-analyst--investor-meeting-at-astro-in-san-diego-300523050.html
SOURCE ViewRay, Inc.
Subscribe to our Free Newsletters!
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...
Intermittent fasting is a complete or partial abstinence from food and caloric drinks for a ...View All